Cargando…
Circulating biomarkers in diagnosis and management of cardiac amyloidosis: a review for internist
Cardiac amyloidosis (CA) is due to extracellular myocardial deposition of misfolded proteins resulting in severe cardiac dysfunction and death. The precursors of amyloid fibrils, able of determining a relevant cardiac infiltration, are immunoglobulin-free light chains (AL amyloidosis) and transthyre...
Autores principales: | Perfetto, Federico, Zampieri, Mattia, Fumagalli, Carlo, Allinovi, Marco, Cappelli, Francesco |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9135845/ https://www.ncbi.nlm.nih.gov/pubmed/35325395 http://dx.doi.org/10.1007/s11739-022-02958-2 |
Ejemplares similares
-
Transthyretin Cardiac Amyloidosis: A Cardio-Orthopedic Disease
por: Perfetto, Federico, et al.
Publicado: (2022) -
Arrhythmic Burden in Cardiac Amyloidosis: What We Know and What We Do Not
por: Argirò, Alessia, et al.
Publicado: (2022) -
Prevalence of anxiety and depression symptoms in a sample of outpatients with ATTR cardiac amyloidosis
por: Smorti, Martina, et al.
Publicado: (2023) -
Does this patient have COVID-19? A practical guide for the internist
por: Bertolino, Lorenzo, et al.
Publicado: (2020) -
A multidisciplinary case report of multiple myeloma with renal and cardiac involvement: a look beyond amyloidosis
por: Innocenti, Samantha, et al.
Publicado: (2022)